Apricus Biosciences
Apricus Biosciences
Employees:
10
Market Cap:
$13.74 million
Revenue:
$6 million
5 Year Trend:
7.0%
Net Income:
$-4.83 million
Stock:
APRI

Apricus Biosciences, Inc. is a San Diego based biopharmaceutical company advancing innovative medicines in urology and rheumatology. Apricus Biosciences' first product, Vitaros®, has been approved in Europe and Canada for the treatment of erectile dysfunction Other compounds in development include: low testosterone, rheumatology, sexual dysfunction, pain, Until September 10, 2010, when it formally changed its name, Apricus Biosciences, Inc. (NASDAQ: APRI) had been operating in the pharmaceutical industry since 1995 under the name NexMed, Inc. Wikipedia

Apricus Biosciences
Are you from Apricus Biosciences?

Apricus Biosciences, Inc. is a San Diego based biopharmaceutical company advancing innovative medicines in urology and rheumatology. Apricus Biosciences' first product, Vitaros®, has been approved in Europe and Canada for the treatment of erectile dysfunction Other compounds in development include: low testosterone, rheumatology, sexual dysfunction, pain, Until September 10, 2010, when it formally changed its name, Apricus Biosciences, Inc. (NASDAQ: APRI) had been operating in the pharmaceutical industry since 1995 under the name NexMed, Inc. Wikipedia

Employees:
10
Market Cap:
$13.74 million
Revenue:
$6 million
5 Year Trend:
7.0%
Net Income:
$-4.83 million
Stock:
APRI

Jobs at at Apricus Biosciences

There are no jobs at the current time